CAS No.:18883-66-4
Name: Streptozocin
Details Introduction
TOXICITY DATA with REFERENCE:
Streptozoticin (18883-66-4) has been listed as a carcinogen by NTP: Suspect carcinogen and IARC: Group 2B carcinogen. Its result of Ames-test is positive. And the toxicological properties have not been fully investigated. You can see actual entry in RTECS for complete information.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 50mg/kg (50mg/kg) | Journal of Medicinal Chemistry. Vol. 19, Pg. 918, 1976. | |
human | TDLo | intravenous | 1044mg/kg/5D (1044mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING LIVER: LIVER FUNCTION TESTS IMPAIRED KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Cancer Vol. 34, Pg. 993, 1974. |
monkey | LDLo | intravenous | 80mg/kg (80mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Drug and Chemical Toxicology. Vol. 3, Pg. 201, 1980. |
mouse | LD50 | intraperitoneal | 360mg/kg (360mg/kg) | Journal of Medicinal Chemistry. Vol. 19, Pg. 918, 1976. | |
mouse | LD50 | intravenous | 275mg/kg (275mg/kg) | Journal of Medicinal Chemistry. Vol. 19, Pg. 918, 1976. | |
mouse | LD50 | parenteral | 264mg/kg (264mg/kg) | Cancer Chemotherapy Reports. Vol. 48, Pg. 1, 1965. | |
mouse | LD50 | subcutaneous | 335mg/kg (335mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
rat | LD50 | intravenous | 138mg/kg (138mg/kg) | Cancer Chemotherapy Reports. Vol. 29, Pg. 91, 1963. | |
women | LDLo | intravenous | 440mg/kg/65W- (440mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM DUODENUM KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED |
Gut. Vol. 12, Pg. 717, 1971. |
women | TDLo | intravenous | 13513ug/kg (13.513mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION |
New England Journal of Medicine. Vol. 311, Pg. 798, 1984. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes:Xn,
T
Risk Statements: 40-61-46-45-22-20/21/22
R40:Limited evidence of a carcinogenic effect.
R61:May cause harm to the unborn child.
R46:May cause heritable genetic damage.
R45:May cause cancer.
R22:Harmful if swallowed.
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 36/37-53-45-36-22
S36/37:Wear suitable protective clothing and gloves.
S53:Avoid exposure - obtain special instructions before use.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36:Wear suitable protective clothing.
S22:Do not breathe dust.
RIDADR: 3249
WGK Germany: 3
RTECS: LZ5775000
F: 3-10-21
HazardClass: 6.1(b)
PackingGroup: III
Standards and Recommendations:
Analytical Methods:
Related Searches

Related Suppliers
- Afine Chemicals Limited
- Dayang Chem (Hangzhou) Co.,Ltd.
- LIDE PHARMACEUTICALS LIMITED
- Shaanxi King Stone Enterprise Company Limited
- SHAANXI TOP PHARM CHEMICAL CO.LTD
- Ferro Pfanstiehl Laboratories, Inc.
- Lanospharma Laboratories Co.,Ltd
- GreatAp Chemicals Co.Ltd.
- Shanghai FWD Chemicals ltd
- Melone Pharmaceutical Co., ltd
- Chengdu Yuyang High-Tech Developing Co., Ltd.
- Taizhou Chemedir Biopharm-tech Co., Ltd
- SEEBIO BIOTECH(SHANGHAI)CO.,LTD.
- Chemieliva Pharmaceutical Co., Ltd.
- Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
- AXXORA, LLC
- Beijing Chemsynlab Pharmaceutical Science & Technology Co. Ltd.
- BIOMOL
- AppliChem GmbH
- SEQUOIA
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione